Sign up to save your podcasts
Or
Share Kisunla: New FDA-Approved Alzheimer's Drug Explained
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Kisunla: New FDA-Approved Alzheimer's Drug Explained
On this special episode we’re discussing the new FDA-approved drug Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We’re joined by Dr. Margarita Reyes, a physician at Bristol Health Group in Connecticut, who explains how Kisunla works, the difference between Kisunla and Leqembi, side effects, and much more.
Need assistance? Call the Alzheimer’s Association 24/7 Helpline (800.272.3900).
View all episodes
By Alzheimer's Association New England Region
5
77 ratings
On this special episode we’re discussing the new FDA-approved drug Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We’re joined by Dr. Margarita Reyes, a physician at Bristol Health Group in Connecticut, who explains how Kisunla works, the difference between Kisunla and Leqembi, side effects, and much more.
Need assistance? Call the Alzheimer’s Association 24/7 Helpline (800.272.3900).
More shows like Speaking of Alzheimer's
View all
Fresh Air
38,151 Listeners
The Moth
27,309 Listeners
Planet Money
30,974 Listeners
TED Radio Hour
22,123 Listeners
Hidden Brain
43,482 Listeners
Nutrition Facts with Dr. Greger
3,453 Listeners
The Proof with Simon Hill
2,606 Listeners
The Dr. Hyman Show
9,358 Listeners
Chasing Life
8,225 Listeners
SmartLess
57,719 Listeners
Good Inside with Dr. Becky
4,341 Listeners
A Slight Change of Plans
2,033 Listeners
All There Is with Anderson Cooper
9,562 Listeners
Truth, Lies & Alzheimer's
14 Listeners
Letters from an American
5,090 Listeners